Home
Categories
EXPLORE
True Crime
Comedy
Society & Culture
Business
Sports
History
News
About Us
Contact Us
Copyright
© 2024 PodJoint
00:00 / 00:00
Sign in

or

Don't have an account?
Sign up
Forgot password
https://is1-ssl.mzstatic.com/image/thumb/Podcasts221/v4/ca/f9/f1/caf9f140-9c1f-3b03-fa4d-156eb8f0e5b7/mza_2240201788367507898.jpg/600x600bb.jpg
The Resilient Investor
Doceo Group
19 episodes
7 months ago
The healthcare sector is undergoing a major shift, from the rise of GLP-1 obesity drugs to increasing pressure on global health systems. Bellevue Healthcare Trust’s Paul Major explores how innovation, efficiency, and investment trends are shaping the future.
Show more...
Investing
Business
RSS
All content for The Resilient Investor is the property of Doceo Group and is served directly from their servers with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
The healthcare sector is undergoing a major shift, from the rise of GLP-1 obesity drugs to increasing pressure on global health systems. Bellevue Healthcare Trust’s Paul Major explores how innovation, efficiency, and investment trends are shaping the future.
Show more...
Investing
Business
https://storage.buzzsprout.com/pm68peyzex7wwxvhzlszaty8z10w?.jpg
The Resilient Investor - The anatomy of a bear market and a psychedelic excursion
The Resilient Investor
35 minutes
3 years ago
The Resilient Investor - The anatomy of a bear market and a psychedelic excursion
In this first episode of The Resilient Investor, David and Sam discuss what a bear market looks like historically and how that compares to the capitulation in 2022. Why have certain stocks fallen so far while others have remained more resilient? They explore various factors causing these variable price moves as well as where opportunities may be found for shrewd investors. David pitches psychedelic drug manufacturers as potential winners.
The Resilient Investor
The healthcare sector is undergoing a major shift, from the rise of GLP-1 obesity drugs to increasing pressure on global health systems. Bellevue Healthcare Trust’s Paul Major explores how innovation, efficiency, and investment trends are shaping the future.